Skip to content

Healthtech investor NLC announces new €20m fund to take startups from lab bench to exit – Sifted

Healthtech investor NLC announces new €20m fund to take startups from lab bench to exit – Sifted

Dutch-headquartered venture builder NLC has announced a first close of €20m for its new health impact fund, from which it will invest in 40 startups, both new investments and follow-on. It’s targeting a final close of €100m.NLC isn’t a normal healthtech VC. It has an 80-strong team responsible for tracking down patents at universities across Europe and then helping cofound startups based on those patents. The team sources an external cofounder and backs the new companies with both capital and support for potentially years, until they have a product ready for market. They work across biotech, medtech, green health and digital… 

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *